Client: Antios Therapeutics
Agency: Digizyme, Inc.
Contribution: Worked with team members and led animation
Year: 2022
Media: Autodesk Maya, Adobe Illustrator, Adobe After Effects

This pharmaceutical animation describes the life cycle of the hepatitis B virus (HBV) and how Antios Therapeutics’ drug candidate interrupts the HBV life cycle: by binding to the viral polymerase to prevent replication of the viral genome.

2D assets and animation and final compositing by Brittany Cheung
Storyboard by Sarah Crawley
3D assets and animation by Jonathan Khao
T cells and hepatocytes by Eric Keller
Narration by Jeannie Park